BR9713587A - Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas - Google Patents

Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas

Info

Publication number
BR9713587A
BR9713587A BR9713587-9A BR9713587A BR9713587A BR 9713587 A BR9713587 A BR 9713587A BR 9713587 A BR9713587 A BR 9713587A BR 9713587 A BR9713587 A BR 9713587A
Authority
BR
Brazil
Prior art keywords
benzoic acid
therapeutic applications
derivatives
piperazinyl
preparing
Prior art date
Application number
BR9713587-9A
Other languages
English (en)
Inventor
Gerard Moinet
Gerard Botton
Liliane Doare
Micheline Kergoat
Didier Messangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR9713587A publication Critical patent/BR9713587A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção:<B>"DERIVADOS DE áCIDO 4-(1-PIPERAZINIL) BENZóICO, PROCESSO PARA PREPARAçãO DOS MESMOS E SUAS APLICAçõES TERAPêUTICAS"<D>. A presente invenção refere-se aos compostos da fórmula (I) em que Ar, R~ 1~, R~ 2~, R~ 3~, R~ 4~, R~ 5~ e R~ 6~ têm os significados dados na reivindicação 1. Esses compostos são úteis no tratamento de diabetes.
BR9713587-9A 1996-12-18 1997-12-15 Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas BR9713587A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615588A FR2757158B1 (fr) 1996-12-18 1996-12-18 Nouveaux derives d'acide 4-(1-piperazinyl) benzoique, leur procede de preparation et leurs applications therapeutiques
PCT/EP1997/007046 WO1998027078A1 (en) 1996-12-18 1997-12-15 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications

Publications (1)

Publication Number Publication Date
BR9713587A true BR9713587A (pt) 2000-04-04

Family

ID=9498818

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713587-9A BR9713587A (pt) 1996-12-18 1997-12-15 Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas

Country Status (26)

Country Link
US (1) US6281215B1 (pt)
EP (1) EP0937054B1 (pt)
JP (1) JP2001506645A (pt)
KR (1) KR20000069544A (pt)
CN (1) CN1073102C (pt)
AR (1) AR013889A1 (pt)
AT (1) ATE218558T1 (pt)
AU (1) AU726640B2 (pt)
BR (1) BR9713587A (pt)
CA (1) CA2275346A1 (pt)
CZ (1) CZ218999A3 (pt)
DE (1) DE69713128T2 (pt)
DK (1) DK0937054T3 (pt)
ES (1) ES2178039T3 (pt)
FR (1) FR2757158B1 (pt)
HU (1) HUP0000586A3 (pt)
ID (1) ID23671A (pt)
NO (1) NO312896B1 (pt)
PL (1) PL334187A1 (pt)
PT (1) PT937054E (pt)
RU (1) RU2178786C2 (pt)
SK (1) SK282841B6 (pt)
TR (1) TR199901367T2 (pt)
UA (1) UA56206C2 (pt)
WO (1) WO1998027078A1 (pt)
ZA (1) ZA9711329B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
US6476046B1 (en) 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
CN101417988B (zh) * 2007-10-24 2011-04-27 山东轩竹医药科技有限公司 双胍哌嗪类二肽酰肽酶ⅳ抑制剂
CN101781273B (zh) * 2009-01-21 2012-07-04 山东轩竹医药科技有限公司 含有胍基的二肽酰肽酶ⅳ抑制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2346011A1 (fr) * 1976-02-02 1977-10-28 Orsymonde Acetanilido-piperazines
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
FR2693722B1 (fr) * 1992-07-16 1994-10-14 Meram Lab Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
IT1278960B1 (it) * 1995-02-24 1997-12-02 Elitas S N C Di Belluzzi Lino Macchina tamponatrice per impregnare superficialmente pelli o simili.
HUP9602977A3 (en) * 1995-02-28 1998-01-28 Daiichi Asubio Pharma Co Ltd Arylpiperidine and arylpiperazine derivatives and drugs containing the same

Also Published As

Publication number Publication date
JP2001506645A (ja) 2001-05-22
EP0937054A1 (en) 1999-08-25
NO992968D0 (no) 1999-06-17
CN1073102C (zh) 2001-10-17
TR199901367T2 (xx) 1999-10-21
DE69713128D1 (de) 2002-07-11
AU5758298A (en) 1998-07-15
CA2275346A1 (en) 1998-06-25
NO992968L (no) 1999-08-17
FR2757158B1 (fr) 1999-04-02
DE69713128T2 (de) 2003-03-20
ID23671A (id) 2000-05-11
ZA9711329B (en) 1998-06-24
ES2178039T3 (es) 2002-12-16
AR013889A1 (es) 2001-01-31
UA56206C2 (uk) 2003-05-15
HUP0000586A2 (hu) 2001-04-28
PT937054E (pt) 2002-11-29
AU726640B2 (en) 2000-11-16
SK78599A3 (en) 2000-03-13
DK0937054T3 (da) 2002-09-16
HUP0000586A3 (en) 2002-10-28
FR2757158A1 (fr) 1998-06-19
SK282841B6 (sk) 2002-12-03
KR20000069544A (ko) 2000-11-25
ATE218558T1 (de) 2002-06-15
CZ218999A3 (cs) 1999-09-15
PL334187A1 (en) 2000-02-14
NO312896B1 (no) 2002-07-15
US6281215B1 (en) 2001-08-28
RU2178786C2 (ru) 2002-01-27
EP0937054B1 (en) 2002-06-05
CN1245494A (zh) 2000-02-23
WO1998027078A1 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
BR9916732A (pt) Derivados de ácido malÈnico, processo para a sua preparação, seu uso e composições farmacêuticas contendo-os (inibição da atividade do fator xa)
BR9916633A (pt) Benzopiranos e benzoxepinas, composições farmacêuticas compreendendo-as e processo de preparação
BR9808953A (pt) Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
BR0212008A (pt) Uso de um composto ou de um sal, solvato ou pró-medicamento deste, composição farmacêutica, composto ou um sal, solvato ou pró-medicamento deste, e, processo para a preparação deste
BR0115769A (pt) Compostos bisarila orto e meta substituìdos, processo para sua preparação, seu emprego como medicamento, assim como preparados farmacêuticos contendo-os
FI942075A (fi) Sappihappojohdannaisten tetratsolijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
EE03869B1 (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
BR0009486A (pt) Compostos que contêm uma amida, utilização desses compostos, composição farmacêutica, processo para o tratamento profilático ou terapêutico de, diabetes do tipo ii e processo para a preparação dos compostos
BR0009641A (pt) Derivados de 1,4-benzotiazepin-1,1-dióxido, substituìdos com radicais de açúcar, processo para produção dos mesmos, medicamentos contendo esses compostos e sua utilização
BR0113989A (pt) Compostos, composições farmacêuticas, processo para a preparação de uma composição farmacêutica, e, uso de pelo menos um dos compostos
BR0108694A (pt) Derivados de ácido malÈnico, processo para preparação dos mesmos, uso dos mesmos como inibidor de atividade do fator xa e composições farmacêuticas que contêm os mesmos
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR0015147A (pt) Ciclopropanos como cgrp-antagonistas, medicamentos contendo os ditos compostos e processo para a produção dos mesmos
DOP2002000512A (es) Sales de acido succinato de 5,7,14-triazatetraciclo [10.3.1.0² ¹¹.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
BR9007758A (pt) Processo para inibir o crescimento ou replicacao dos virus da imuno deficiencia humana,compostos,composto intermediario e formulacao farmaceutica para inibir o crescimento ou replicacao do hiv
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
BR0016678A (pt) Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto
BR9916669A (pt) Uso de derivados de ácidos 4-biarilbutìricos e 5-biarilpentanóicos substituìdos como inibidores de metaloproteases de matriz para o tratamento de doenças respiratórias
BR0309014A (pt) ácido(2-((2-alcóxi)-fenil)-ciclopent-1-enil)carbo e heterocìclico aromático e derivados
BR9713587A (pt) Derivados de ácido 4-(1-piperazinil) benzóico, processo para preparação dos mesmos e suas aplicações terapêuticas
BR9915436A (pt) Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
PT95651A (pt) Processo para a preparacao de derivados de benzo-ciclo-alquilamino-piridinaminas e de composicoes farmaceuticas que os contem
PT92952A (pt) Processo para a preparacao de acidos 3-fenil-5,6-di-hidrobenz { c }acridina-7- carboxilicos, de compostos relacionados e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.